Skip to main content Skip to section navigation Skip to footer
ProMIS Neurosciences, Inc.
  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Business Advisory Board
  • Our Science
  • Product Pipeline
    • Overview
    • Alzheimer’s Disease
    • ALS
    • MSA
    • Parkinson’s Disease
    • Posters & Publications
  • News & Media
    • Press Releases
    • Corporate Presentations
    • Events
    • In The News
    • Videos
    • Commentary
    • Podcasts
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • SEC Filings
    • Governance
  • Careers
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Corporate Presentations
  • Events
  • In The News
  • Videos
  • Commentary
  • Podcasts
May 14, 2021 7:00am EDT

ProMIS Neurosciences Announces First Quarter 2021 Results

May 12, 2021 6:30am EDT

ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, as Chair of Scientific Advisory Board

Mar 31, 2021 7:30am EDT

ProMIS Neurosciences Announces Fiscal Year 2020 Results

Mar 22, 2021 10:44am EDT

ProMIS Neurosciences Completes US$7M (CDN$8.75M) Financing with Distinguished Group of Boston Based Investors

Feb 02, 2021 8:30am EST

ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer’s/Amyloid Field

Jan 12, 2021 6:30am EST

ProMIS Neurosciences Announces Strategic Priorities for 2021

Nov 16, 2020 4:48pm EST

ProMIS Neurosciences Completes Offering of Special Warrants

Nov 11, 2020 6:30am EST

ProMIS Neurosciences Announces Third Quarter 2020 Results

Nov 09, 2020 6:30am EST

ProMIS Neurosciences offers comments on recent FDA Advisory Committee meeting on aducanumab for the treatment of Alzheimer’s disease

Nov 05, 2020 6:30am EST

ProMIS Neurosciences Closes First Tranche of Private Placement

  • arrow_back
  • 1…
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …19
  • arrow_forward
Facebook Linkedin Spotify Twitter
©2023 ProMIS Neurosciences, Inc. All Rights Reserved.
Disclaimer Sitemap Cookie Policy Privacy Policy